Hormone Therapy Does Not Worsen Lupus But May Increase Thrombosis Risk
Thursday, September 13, 2007
Women with systemic lupus erythematosus (SLE) are at increased risk for premature menopause, with its attendant risks of osteoporotic fracture, however, hormone therapy (HT) is a possible treatment. Jorge Sanchez-Guerrero, MD, MS, and colleagues have conducted a double-blind, randomized, clinical trial allaying concerns that HT might worsen SLE activity but reinforcing fears that HT might add to an already elevated risk of thrombosis in women with SLE. The study is reported in Arthritis & Rheumatism.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms